| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphocytosis | 3 | 2024 | 119 | 1.380 |
Why?
|
| Celiac Disease | 9 | 2024 | 785 | 1.290 |
Why?
|
| Barrett Esophagus | 4 | 2020 | 494 | 1.270 |
Why?
|
| Gastritis | 5 | 2023 | 196 | 1.250 |
Why?
|
| Immunohistochemistry | 26 | 2023 | 11366 | 1.190 |
Why?
|
| Principal Component Analysis | 4 | 2022 | 940 | 1.080 |
Why?
|
| Pathology, Clinical | 5 | 2017 | 368 | 0.970 |
Why?
|
| Laboratories | 5 | 2019 | 463 | 0.870 |
Why?
|
| Intestinal Mucosa | 13 | 2024 | 3036 | 0.860 |
Why?
|
| Intestinal Atresia | 1 | 2022 | 68 | 0.810 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2022 | 224 | 0.740 |
Why?
|
| Colonic Polyps | 2 | 2022 | 542 | 0.740 |
Why?
|
| Helicobacter pylori | 5 | 2023 | 382 | 0.700 |
Why?
|
| Ileitis | 1 | 2019 | 44 | 0.690 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2022 | 223 | 0.690 |
Why?
|
| Colitis, Ulcerative | 6 | 2022 | 1912 | 0.610 |
Why?
|
| Helicobacter Infections | 4 | 2023 | 386 | 0.600 |
Why?
|
| Esophagus | 4 | 2018 | 1019 | 0.570 |
Why?
|
| Time | 1 | 2018 | 542 | 0.570 |
Why?
|
| Benchmarking | 3 | 2021 | 1042 | 0.550 |
Why?
|
| Arsenic | 3 | 2024 | 328 | 0.550 |
Why?
|
| Amyloidosis | 5 | 2020 | 795 | 0.530 |
Why?
|
| Malabsorption Syndromes | 3 | 2023 | 135 | 0.530 |
Why?
|
| Gastritis, Atrophic | 1 | 2015 | 31 | 0.530 |
Why?
|
| Air Pollution | 7 | 2022 | 2286 | 0.520 |
Why?
|
| Gastric Mucosa | 6 | 2023 | 599 | 0.510 |
Why?
|
| Colitis | 7 | 2023 | 1170 | 0.500 |
Why?
|
| Gastroesophageal Reflux | 2 | 2020 | 782 | 0.490 |
Why?
|
| Intestinal Diseases | 3 | 2023 | 530 | 0.490 |
Why?
|
| Gastrointestinal Tract | 1 | 2020 | 814 | 0.470 |
Why?
|
| Colon | 7 | 2020 | 1772 | 0.470 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 1788 | 0.470 |
Why?
|
| Models, Statistical | 7 | 2022 | 5102 | 0.460 |
Why?
|
| Soft Tissue Neoplasms | 7 | 2023 | 1363 | 0.460 |
Why?
|
| Child | 41 | 2024 | 77709 | 0.450 |
Why?
|
| Tissue Fixation | 2 | 2011 | 241 | 0.450 |
Why?
|
| Vascular Neoplasms | 1 | 2015 | 175 | 0.440 |
Why?
|
| Humans | 178 | 2024 | 744343 | 0.440 |
Why?
|
| Seasons | 2 | 2016 | 1493 | 0.430 |
Why?
|
| Esophagitis | 1 | 2014 | 152 | 0.430 |
Why?
|
| Biopsy | 15 | 2024 | 6756 | 0.430 |
Why?
|
| Laboratories, Hospital | 2 | 2016 | 194 | 0.420 |
Why?
|
| Regression Analysis | 6 | 2018 | 6459 | 0.410 |
Why?
|
| Eosinophilic Esophagitis | 3 | 2019 | 168 | 0.410 |
Why?
|
| Liposarcoma | 1 | 2015 | 333 | 0.400 |
Why?
|
| Duodenum | 5 | 2024 | 483 | 0.400 |
Why?
|
| Vena Cava, Inferior | 1 | 2015 | 440 | 0.400 |
Why?
|
| Metaplasia | 3 | 2023 | 313 | 0.400 |
Why?
|
| Linear Models | 4 | 2022 | 5952 | 0.390 |
Why?
|
| Staining and Labeling | 2 | 2017 | 1100 | 0.390 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 2716 | 0.390 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2023 | 2425 | 0.370 |
Why?
|
| Intestinal Polyposis | 1 | 2010 | 44 | 0.360 |
Why?
|
| Proteins | 2 | 2022 | 6103 | 0.360 |
Why?
|
| Diarrhea, Infantile | 2 | 2021 | 109 | 0.350 |
Why?
|
| Exercise | 5 | 2023 | 5615 | 0.350 |
Why?
|
| Mesenchymoma | 1 | 2009 | 47 | 0.350 |
Why?
|
| Mucolipidoses | 2 | 2023 | 82 | 0.340 |
Why?
|
| Fibroma | 3 | 2014 | 212 | 0.340 |
Why?
|
| Algorithms | 9 | 2022 | 13881 | 0.340 |
Why?
|
| Receptor, erbB-2 | 4 | 2023 | 2416 | 0.340 |
Why?
|
| Peripheral Nervous System Neoplasms | 3 | 2014 | 122 | 0.330 |
Why?
|
| Glutens | 3 | 2023 | 230 | 0.330 |
Why?
|
| Esophagogastric Junction | 2 | 2020 | 313 | 0.320 |
Why?
|
| Folic Acid | 3 | 2023 | 1300 | 0.320 |
Why?
|
| Colonoscopy | 4 | 2022 | 1367 | 0.300 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2022 | 2408 | 0.300 |
Why?
|
| Fibromatosis, Aggressive | 3 | 2013 | 118 | 0.300 |
Why?
|
| Pathology, Surgical | 1 | 2008 | 155 | 0.300 |
Why?
|
| Environmental Pollutants | 3 | 2022 | 1179 | 0.290 |
Why?
|
| Female | 96 | 2023 | 380194 | 0.290 |
Why?
|
| Schools | 1 | 2015 | 1433 | 0.280 |
Why?
|
| Male | 90 | 2023 | 350118 | 0.280 |
Why?
|
| Diarrhea | 4 | 2021 | 1348 | 0.270 |
Why?
|
| Cadmium | 2 | 2024 | 212 | 0.270 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 6773 | 0.260 |
Why?
|
| Computer Graphics | 2 | 2018 | 361 | 0.260 |
Why?
|
| Wnt Proteins | 2 | 2021 | 721 | 0.260 |
Why?
|
| Bacterial Toxins | 2 | 2023 | 931 | 0.260 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2011 | 957 | 0.260 |
Why?
|
| New York City | 4 | 2024 | 710 | 0.250 |
Why?
|
| Bayes Theorem | 5 | 2022 | 2309 | 0.250 |
Why?
|
| Stroke | 3 | 2023 | 9981 | 0.250 |
Why?
|
| Wetlands | 1 | 2024 | 11 | 0.240 |
Why?
|
| Adolescent | 29 | 2023 | 85781 | 0.240 |
Why?
|
| Helicobacter heilmannii | 1 | 2023 | 5 | 0.240 |
Why?
|
| Prealbumin | 3 | 2020 | 210 | 0.240 |
Why?
|
| Histological Techniques | 2 | 2016 | 198 | 0.240 |
Why?
|
| Myxosarcoma | 1 | 2023 | 15 | 0.230 |
Why?
|
| Environmental Exposure | 8 | 2023 | 4234 | 0.230 |
Why?
|
| Myosin Type V | 1 | 2023 | 34 | 0.230 |
Why?
|
| Lymphocytes | 2 | 2024 | 2617 | 0.230 |
Why?
|
| Neurogenic Inflammation | 1 | 2023 | 33 | 0.230 |
Why?
|
| Poverty | 1 | 2015 | 2660 | 0.230 |
Why?
|
| Sciatic Neuropathy | 2 | 2013 | 74 | 0.220 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2009 | 643 | 0.220 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2003 | 84 | 0.220 |
Why?
|
| Multiple Sclerosis | 3 | 2014 | 3079 | 0.220 |
Why?
|
| Air Pollutants | 3 | 2022 | 2817 | 0.220 |
Why?
|
| Intestines | 4 | 2022 | 1924 | 0.220 |
Why?
|
| Feeding Behavior | 1 | 2015 | 3188 | 0.220 |
Why?
|
| Cystadenoma, Serous | 1 | 2003 | 102 | 0.220 |
Why?
|
| Arsenicals | 1 | 2023 | 124 | 0.220 |
Why?
|
| Child, Preschool | 19 | 2023 | 41006 | 0.210 |
Why?
|
| Lipomatosis | 2 | 2013 | 112 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.210 |
Why?
|
| Trace Elements | 1 | 2024 | 198 | 0.210 |
Why?
|
| Infant | 17 | 2023 | 35136 | 0.210 |
Why?
|
| Gastrointestinal Diseases | 3 | 2020 | 1170 | 0.210 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2002 | 83 | 0.210 |
Why?
|
| Enterocytes | 3 | 2023 | 225 | 0.210 |
Why?
|
| Diet, Gluten-Free | 3 | 2023 | 271 | 0.210 |
Why?
|
| Duodenitis | 1 | 2021 | 18 | 0.200 |
Why?
|
| Qa-SNARE Proteins | 1 | 2021 | 55 | 0.200 |
Why?
|
| Sarcoma | 4 | 2017 | 1897 | 0.200 |
Why?
|
| Motor Activity | 3 | 2018 | 2714 | 0.200 |
Why?
|
| Retrospective Studies | 26 | 2024 | 77449 | 0.200 |
Why?
|
| Flame Retardants | 1 | 2022 | 87 | 0.200 |
Why?
|
| Pathology | 2 | 2017 | 272 | 0.200 |
Why?
|
| Glycoproteins | 2 | 2021 | 2263 | 0.200 |
Why?
|
| Saccharomyces | 2 | 2013 | 65 | 0.200 |
Why?
|
| Hemangiopericytoma | 1 | 2001 | 77 | 0.200 |
Why?
|
| Fibrosarcoma | 1 | 2023 | 348 | 0.200 |
Why?
|
| Colonic Neoplasms | 2 | 2010 | 2541 | 0.200 |
Why?
|
| Recovery of Function | 3 | 2023 | 2925 | 0.190 |
Why?
|
| Reproducibility of Results | 15 | 2023 | 19905 | 0.190 |
Why?
|
| Bone Neoplasms | 3 | 2023 | 2529 | 0.190 |
Why?
|
| Hemangioma | 2 | 2019 | 738 | 0.190 |
Why?
|
| Neurons, Afferent | 1 | 2023 | 506 | 0.190 |
Why?
|
| Selenium | 1 | 2024 | 405 | 0.190 |
Why?
|
| Adult | 54 | 2024 | 214055 | 0.190 |
Why?
|
| Pericytes | 1 | 2023 | 292 | 0.190 |
Why?
|
| Food Supply | 2 | 2024 | 524 | 0.190 |
Why?
|
| Research Design | 3 | 2021 | 5987 | 0.190 |
Why?
|
| Food | 2 | 2023 | 771 | 0.180 |
Why?
|
| I-kappa B Kinase | 1 | 2021 | 252 | 0.180 |
Why?
|
| Goiter | 1 | 2000 | 87 | 0.180 |
Why?
|
| Pancreas | 5 | 2017 | 1686 | 0.180 |
Why?
|
| Disorders of Sex Development | 1 | 2021 | 122 | 0.180 |
Why?
|
| Microvilli | 2 | 2023 | 241 | 0.180 |
Why?
|
| Immunologic Tests | 1 | 2020 | 103 | 0.180 |
Why?
|
| Computer Simulation | 4 | 2018 | 6196 | 0.180 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2021 | 294 | 0.180 |
Why?
|
| Epilepsy | 4 | 2016 | 3310 | 0.180 |
Why?
|
| Duodenal Diseases | 1 | 2020 | 102 | 0.180 |
Why?
|
| Coronary Care Units | 2 | 1998 | 214 | 0.180 |
Why?
|
| Haploinsufficiency | 2 | 2022 | 328 | 0.180 |
Why?
|
| Leiomyosarcoma | 2 | 2017 | 477 | 0.180 |
Why?
|
| Formaldehyde | 2 | 2011 | 353 | 0.180 |
Why?
|
| Complex Mixtures | 1 | 2019 | 28 | 0.180 |
Why?
|
| Spinal Canal | 1 | 2019 | 39 | 0.170 |
Why?
|
| Growth and Development | 1 | 2019 | 52 | 0.170 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 63 | 0.170 |
Why?
|
| Short Bowel Syndrome | 1 | 2023 | 345 | 0.170 |
Why?
|
| Endoscopy, Digestive System | 2 | 2019 | 345 | 0.170 |
Why?
|
| Orbital Neoplasms | 1 | 2001 | 225 | 0.170 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2003 | 506 | 0.170 |
Why?
|
| Immune System Diseases | 1 | 2021 | 262 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2013 | 3327 | 0.170 |
Why?
|
| Fecal Impaction | 1 | 2018 | 34 | 0.170 |
Why?
|
| Coloring Agents | 2 | 2023 | 566 | 0.170 |
Why?
|
| Inflammation | 6 | 2023 | 10638 | 0.160 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 288 | 0.160 |
Why?
|
| Frozen Sections | 1 | 2019 | 155 | 0.160 |
Why?
|
| Chondroma | 1 | 2018 | 58 | 0.160 |
Why?
|
| Eye Abnormalities | 1 | 2021 | 246 | 0.160 |
Why?
|
| Indians, North American | 1 | 2022 | 355 | 0.160 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2017 | 15 | 0.160 |
Why?
|
| Ampulla of Vater | 1 | 2018 | 141 | 0.160 |
Why?
|
| Receptors, IgG | 1 | 2021 | 582 | 0.150 |
Why?
|
| Particulate Matter | 4 | 2022 | 2530 | 0.150 |
Why?
|
| Cytomegalovirus Infections | 2 | 2021 | 820 | 0.150 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2020 | 138 | 0.150 |
Why?
|
| DNA, Mitochondrial | 1 | 2023 | 817 | 0.150 |
Why?
|
| Muscles | 1 | 2002 | 1614 | 0.150 |
Why?
|
| Enteroendocrine Cells | 1 | 2018 | 65 | 0.150 |
Why?
|
| Probiotics | 2 | 2013 | 351 | 0.150 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 346 | 0.150 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2021 | 341 | 0.150 |
Why?
|
| Immunophenotyping | 2 | 2020 | 1880 | 0.150 |
Why?
|
| Colectomy | 1 | 2022 | 683 | 0.150 |
Why?
|
| Enterotoxins | 1 | 2018 | 368 | 0.150 |
Why?
|
| Codon, Nonsense | 1 | 2018 | 281 | 0.150 |
Why?
|
| Autoimmunity | 2 | 2022 | 1349 | 0.140 |
Why?
|
| Antigens, CD | 3 | 2021 | 4026 | 0.140 |
Why?
|
| Total Quality Management | 1 | 1998 | 274 | 0.140 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2016 | 50 | 0.140 |
Why?
|
| New York | 4 | 2021 | 886 | 0.140 |
Why?
|
| Middle Aged | 50 | 2021 | 213383 | 0.140 |
Why?
|
| Ileum | 1 | 2019 | 565 | 0.140 |
Why?
|
| Oral Ulcer | 1 | 2017 | 96 | 0.140 |
Why?
|
| Quality Control | 2 | 2016 | 841 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2017 | 299 | 0.140 |
Why?
|
| Reimbursement Mechanisms | 2 | 2012 | 670 | 0.140 |
Why?
|
| Penetrance | 2 | 2015 | 381 | 0.140 |
Why?
|
| Heart Failure, Systolic | 1 | 2017 | 126 | 0.140 |
Why?
|
| Radiography, Interventional | 3 | 2017 | 1095 | 0.140 |
Why?
|
| Clostridium Infections | 2 | 2023 | 548 | 0.140 |
Why?
|
| Histocytochemistry | 3 | 2014 | 719 | 0.140 |
Why?
|
| Skin Ulcer | 1 | 2017 | 120 | 0.140 |
Why?
|
| Enterocolitis | 1 | 2017 | 102 | 0.140 |
Why?
|
| Aged | 36 | 2023 | 163280 | 0.140 |
Why?
|
| Fatigue | 1 | 2023 | 1531 | 0.140 |
Why?
|
| Neurulation | 1 | 2015 | 7 | 0.140 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 275 | 0.140 |
Why?
|
| Syndrome | 1 | 2022 | 3251 | 0.130 |
Why?
|
| Hospital Units | 1 | 1997 | 141 | 0.130 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2016 | 108 | 0.130 |
Why?
|
| Eosinophilia | 1 | 2020 | 541 | 0.130 |
Why?
|
| Energy Metabolism | 3 | 2017 | 2899 | 0.130 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 260 | 0.130 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 1912 | 0.130 |
Why?
|
| Gastrulation | 1 | 2015 | 32 | 0.130 |
Why?
|
| Abdomen | 1 | 2022 | 1118 | 0.130 |
Why?
|
| Motor Cortex | 1 | 2023 | 986 | 0.130 |
Why?
|
| Telemetry | 1 | 1997 | 205 | 0.130 |
Why?
|
| Validation Studies as Topic | 1 | 2015 | 159 | 0.130 |
Why?
|
| Decision Support Techniques | 2 | 2017 | 1956 | 0.130 |
Why?
|
| Genetic Testing | 4 | 2018 | 3444 | 0.130 |
Why?
|
| Genomic Imprinting | 1 | 2017 | 328 | 0.130 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2021 | 770 | 0.130 |
Why?
|
| Biostatistics | 1 | 2017 | 162 | 0.130 |
Why?
|
| Case-Control Studies | 6 | 2024 | 21746 | 0.130 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 236 | 0.130 |
Why?
|
| Mutation, Missense | 2 | 2021 | 2564 | 0.130 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2017 | 182 | 0.130 |
Why?
|
| Hypoglycemia | 2 | 2017 | 861 | 0.130 |
Why?
|
| Epitopes | 2 | 2023 | 2571 | 0.130 |
Why?
|
| Monitoring, Ambulatory | 2 | 2016 | 355 | 0.130 |
Why?
|
| Sample Size | 1 | 2018 | 845 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2018 | 3508 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2018 | 798 | 0.130 |
Why?
|
| Virulence Factors | 1 | 2018 | 509 | 0.130 |
Why?
|
| Cryptococcus | 1 | 2014 | 29 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2018 | 13033 | 0.120 |
Why?
|
| Inferior Colliculi | 1 | 1995 | 68 | 0.120 |
Why?
|
| Coronary Disease | 2 | 2021 | 6077 | 0.120 |
Why?
|
| Diagnosis, Differential | 9 | 2023 | 12959 | 0.120 |
Why?
|
| Genes, Dominant | 1 | 2017 | 880 | 0.120 |
Why?
|
| Central Nervous System Depressants | 1 | 2015 | 167 | 0.120 |
Why?
|
| Signal Transduction | 12 | 2023 | 23403 | 0.120 |
Why?
|
| RNA, Neoplasm | 1 | 2017 | 769 | 0.120 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2016 | 300 | 0.120 |
Why?
|
| Chondromatosis, Synovial | 1 | 2014 | 17 | 0.120 |
Why?
|
| Bursa, Synovial | 1 | 2014 | 24 | 0.120 |
Why?
|
| Dietary Supplements | 2 | 2023 | 3297 | 0.120 |
Why?
|
| Cryptococcosis | 1 | 2014 | 101 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2015 | 205 | 0.120 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 1607 | 0.120 |
Why?
|
| Femoral Neoplasms | 1 | 2014 | 77 | 0.120 |
Why?
|
| Gastric Bypass | 2 | 2017 | 812 | 0.120 |
Why?
|
| Osteochondroma | 1 | 2014 | 47 | 0.120 |
Why?
|
| Stomach Neoplasms | 1 | 2023 | 1333 | 0.120 |
Why?
|
| Models, Biological | 2 | 2022 | 9583 | 0.120 |
Why?
|
| Agammaglobulinemia | 1 | 2015 | 167 | 0.110 |
Why?
|
| Parents | 2 | 2018 | 3407 | 0.110 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 1660 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2018 | 1061 | 0.110 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2017 | 332 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 1061 | 0.110 |
Why?
|
| Actigraphy | 1 | 2017 | 488 | 0.110 |
Why?
|
| Rib Fractures | 1 | 2014 | 131 | 0.110 |
Why?
|
| Young Adult | 16 | 2020 | 56430 | 0.110 |
Why?
|
| Beverages | 1 | 2018 | 820 | 0.110 |
Why?
|
| Environmental Monitoring | 1 | 2019 | 1414 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2021 | 1253 | 0.110 |
Why?
|
| Obesity | 1 | 2015 | 12745 | 0.110 |
Why?
|
| Frail Elderly | 1 | 2017 | 693 | 0.110 |
Why?
|
| Angioplasty, Balloon | 1 | 1997 | 653 | 0.110 |
Why?
|
| Echocardiography | 2 | 2023 | 5102 | 0.110 |
Why?
|
| Adenoma | 1 | 2003 | 2174 | 0.110 |
Why?
|
| Sensitivity and Specificity | 9 | 2019 | 14722 | 0.100 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 1 | 2012 | 37 | 0.100 |
Why?
|
| Aged, 80 and over | 19 | 2020 | 57776 | 0.100 |
Why?
|
| Spinal Neoplasms | 1 | 2019 | 760 | 0.100 |
Why?
|
| Dermatitis, Atopic | 1 | 2019 | 654 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2003 | 1634 | 0.100 |
Why?
|
| Motor Skills | 1 | 2015 | 522 | 0.100 |
Why?
|
| Food Hypersensitivity | 1 | 2019 | 622 | 0.100 |
Why?
|
| Stomach | 2 | 2014 | 697 | 0.100 |
Why?
|
| Multimedia | 1 | 2012 | 77 | 0.100 |
Why?
|
| Checklist | 1 | 2019 | 833 | 0.100 |
Why?
|
| Opportunistic Infections | 1 | 2015 | 389 | 0.100 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2013 | 2305 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2866 | 0.100 |
Why?
|
| Monocytes | 1 | 2021 | 2596 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2022 | 1414 | 0.100 |
Why?
|
| Mast Cells | 1 | 2019 | 1544 | 0.100 |
Why?
|
| Hospital Costs | 1 | 1998 | 985 | 0.100 |
Why?
|
| Biometry | 1 | 2015 | 558 | 0.100 |
Why?
|
| Osteosarcoma | 1 | 2017 | 881 | 0.100 |
Why?
|
| United States | 11 | 2022 | 69872 | 0.100 |
Why?
|
| Running | 1 | 2016 | 480 | 0.100 |
Why?
|
| Family Health | 1 | 2016 | 1282 | 0.100 |
Why?
|
| Endoscopy | 4 | 2016 | 1785 | 0.100 |
Why?
|
| Fixatives | 1 | 2011 | 94 | 0.100 |
Why?
|
| Body Mass Index | 5 | 2023 | 12720 | 0.100 |
Why?
|
| Nutritional Status | 1 | 2019 | 1609 | 0.100 |
Why?
|
| Connective Tissue | 1 | 2013 | 420 | 0.100 |
Why?
|
| Biopsy, Needle | 3 | 2017 | 1641 | 0.100 |
Why?
|
| Metabolome | 2 | 2023 | 895 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2016 | 1200 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 2 | 2012 | 5256 | 0.100 |
Why?
|
| Horseshoe Crabs | 1 | 2010 | 13 | 0.100 |
Why?
|
| Thigh | 3 | 2017 | 247 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 972 | 0.100 |
Why?
|
| Group Processes | 1 | 2012 | 225 | 0.090 |
Why?
|
| Paraffin Embedding | 1 | 2011 | 299 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2022 | 1797 | 0.090 |
Why?
|
| Advisory Committees | 1 | 2015 | 775 | 0.090 |
Why?
|
| Receptors, Progesterone | 3 | 2023 | 1097 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 546 | 0.090 |
Why?
|
| Predictive Value of Tests | 8 | 2019 | 15076 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 20822 | 0.090 |
Why?
|
| Surgical Procedures, Operative | 1 | 2022 | 1876 | 0.090 |
Why?
|
| Brain | 4 | 2021 | 26385 | 0.090 |
Why?
|
| Joints | 1 | 2011 | 326 | 0.090 |
Why?
|
| Foreign-Body Reaction | 1 | 2010 | 157 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 1254 | 0.090 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 198 | 0.090 |
Why?
|
| Critical Pathways | 3 | 2018 | 476 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2017 | 891 | 0.090 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2010 | 84 | 0.090 |
Why?
|
| ROC Curve | 4 | 2022 | 3527 | 0.090 |
Why?
|
| Intraoperative Period | 2 | 2022 | 520 | 0.090 |
Why?
|
| Blood-Brain Barrier | 2 | 2012 | 1017 | 0.090 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2010 | 101 | 0.090 |
Why?
|
| Myositis Ossificans | 1 | 2010 | 79 | 0.090 |
Why?
|
| Child Behavior | 1 | 2015 | 839 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1152 | 0.090 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 1241 | 0.090 |
Why?
|
| Metabolomics | 2 | 2023 | 1484 | 0.090 |
Why?
|
| Angiography | 1 | 2015 | 1639 | 0.080 |
Why?
|
| Foot Diseases | 1 | 2010 | 143 | 0.080 |
Why?
|
| Social Stigma | 1 | 2015 | 701 | 0.080 |
Why?
|
| Biliary Tract | 1 | 2010 | 134 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2019 | 10481 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2017 | 3752 | 0.080 |
Why?
|
| Amino Acids | 1 | 1995 | 1736 | 0.080 |
Why?
|
| Mucins | 1 | 2012 | 564 | 0.080 |
Why?
|
| Ethanol | 1 | 2015 | 1342 | 0.080 |
Why?
|
| Walking | 1 | 2016 | 1180 | 0.080 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2009 | 72 | 0.080 |
Why?
|
| Calibration | 3 | 2017 | 816 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 1164 | 0.080 |
Why?
|
| Heart Transplantation | 2 | 2020 | 3110 | 0.080 |
Why?
|
| Edema | 2 | 2010 | 789 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2015 | 906 | 0.080 |
Why?
|
| Choristoma | 1 | 2010 | 213 | 0.080 |
Why?
|
| Follow-Up Studies | 6 | 2023 | 39050 | 0.080 |
Why?
|
| Esophagoscopy | 1 | 2010 | 390 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2017 | 1102 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2014 | 35421 | 0.080 |
Why?
|
| Pancreatic Cyst | 1 | 2012 | 368 | 0.080 |
Why?
|
| Medical Errors | 1 | 2016 | 1297 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3920 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 1965 | 0.080 |
Why?
|
| Guidelines as Topic | 2 | 2017 | 1405 | 0.080 |
Why?
|
| Age Factors | 3 | 2020 | 18370 | 0.080 |
Why?
|
| Robotics | 1 | 2015 | 899 | 0.080 |
Why?
|
| Body Weight | 2 | 2015 | 4669 | 0.080 |
Why?
|
| Arthroplasty, Replacement | 1 | 2011 | 339 | 0.080 |
Why?
|
| Prevalence | 3 | 2020 | 15226 | 0.080 |
Why?
|
| Urease | 1 | 2007 | 42 | 0.070 |
Why?
|
| Musculoskeletal Diseases | 1 | 2013 | 581 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2021 | 2775 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2017 | 1194 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2020 | 2303 | 0.070 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2018 | 868 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2013 | 1005 | 0.070 |
Why?
|
| Prognosis | 10 | 2020 | 29063 | 0.070 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2012 | 518 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2015 | 1456 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2023 | 9239 | 0.070 |
Why?
|
| Wounds, Penetrating | 1 | 2009 | 307 | 0.070 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 1151 | 0.070 |
Why?
|
| Laparotomy | 1 | 2009 | 473 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2015 | 2052 | 0.070 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2008 | 264 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 2073 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 331 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2008 | 245 | 0.070 |
Why?
|
| Income | 1 | 2015 | 1913 | 0.070 |
Why?
|
| Calorimetry, Indirect | 2 | 2017 | 183 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2017 | 6256 | 0.070 |
Why?
|
| Foreign Bodies | 1 | 2010 | 399 | 0.070 |
Why?
|
| Postoperative Complications | 4 | 2022 | 15295 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 1836 | 0.070 |
Why?
|
| Collagen | 1 | 2014 | 2689 | 0.070 |
Why?
|
| Portal System | 1 | 2005 | 52 | 0.070 |
Why?
|
| Pilot Projects | 3 | 2016 | 8324 | 0.070 |
Why?
|
| Breath Tests | 1 | 2007 | 280 | 0.070 |
Why?
|
| Gastroscopy | 2 | 2023 | 207 | 0.070 |
Why?
|
| Infant, Newborn | 6 | 2023 | 25625 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2011 | 783 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2005 | 57 | 0.070 |
Why?
|
| Accreditation | 1 | 2008 | 450 | 0.070 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 25043 | 0.070 |
Why?
|
| Contrast Media | 3 | 2015 | 5300 | 0.070 |
Why?
|
| Heart Diseases | 2 | 1998 | 2788 | 0.070 |
Why?
|
| Students | 1 | 2015 | 1654 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 13989 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 776 | 0.060 |
Why?
|
| Pregnancy | 7 | 2023 | 29144 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2022 | 23338 | 0.060 |
Why?
|
| Vancomycin | 1 | 2008 | 501 | 0.060 |
Why?
|
| Patient Care Management | 1 | 2008 | 306 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 1486 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 1257 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5221 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2013 | 2440 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2017 | 20129 | 0.060 |
Why?
|
| Single-Blind Method | 2 | 2019 | 1590 | 0.060 |
Why?
|
| Image Enhancement | 2 | 2013 | 2921 | 0.060 |
Why?
|
| Carotid Body Tumor | 1 | 2004 | 32 | 0.060 |
Why?
|
| Incidence | 5 | 2021 | 20947 | 0.060 |
Why?
|
| Prospective Studies | 9 | 2021 | 53288 | 0.060 |
Why?
|
| Teaching | 1 | 2012 | 1174 | 0.060 |
Why?
|
| Radiation Tolerance | 2 | 2004 | 486 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2017 | 2282 | 0.060 |
Why?
|
| Molybdenum | 1 | 2024 | 46 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 2203 | 0.060 |
Why?
|
| Cohort Studies | 7 | 2023 | 40561 | 0.060 |
Why?
|
| Risk Factors | 8 | 2022 | 72290 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2009 | 1355 | 0.060 |
Why?
|
| Neurilemmoma | 1 | 2009 | 547 | 0.060 |
Why?
|
| Agar | 1 | 2023 | 56 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2005 | 422 | 0.060 |
Why?
|
| Cobalt | 1 | 2024 | 158 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3864 | 0.060 |
Why?
|
| Mice | 11 | 2023 | 81183 | 0.060 |
Why?
|
| Thyroidectomy | 2 | 2017 | 879 | 0.060 |
Why?
|
| Arachidonic Acids | 1 | 2023 | 299 | 0.060 |
Why?
|
| Nickel | 1 | 2024 | 130 | 0.060 |
Why?
|
| Dominican Republic | 1 | 2023 | 76 | 0.060 |
Why?
|
| Health Care Costs | 1 | 1997 | 3209 | 0.060 |
Why?
|
| Clarithromycin | 1 | 2023 | 86 | 0.060 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2023 | 129 | 0.060 |
Why?
|
| Abdominal Pain | 2 | 2023 | 1063 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 2916 | 0.060 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2012 | 1008 | 0.050 |
Why?
|
| Cecum | 1 | 2023 | 237 | 0.050 |
Why?
|
| Animals | 16 | 2023 | 168757 | 0.050 |
Why?
|
| Recurrence | 2 | 2016 | 8340 | 0.050 |
Why?
|
| Heart Rate | 1 | 2014 | 4091 | 0.050 |
Why?
|
| Cholecystitis | 1 | 2003 | 182 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 8388 | 0.050 |
Why?
|
| Software | 1 | 2017 | 4443 | 0.050 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2022 | 77 | 0.050 |
Why?
|
| Food, Fortified | 1 | 2023 | 191 | 0.050 |
Why?
|
| Amoxicillin | 1 | 2023 | 170 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2022 | 129 | 0.050 |
Why?
|
| Time Factors | 5 | 2021 | 40075 | 0.050 |
Why?
|
| Substance P | 1 | 2023 | 335 | 0.050 |
Why?
|
| Reference Standards | 2 | 2017 | 1025 | 0.050 |
Why?
|
| Pancreatic Diseases | 1 | 2004 | 350 | 0.050 |
Why?
|
| Metronidazole | 1 | 2023 | 217 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 1416 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2023 | 2187 | 0.050 |
Why?
|
| Medicaid | 2 | 2012 | 2736 | 0.050 |
Why?
|
| Choline | 1 | 2023 | 493 | 0.050 |
Why?
|
| Dextran Sulfate | 2 | 2017 | 236 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 772 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2023 | 414 | 0.050 |
Why?
|
| Expert Testimony | 2 | 2015 | 356 | 0.050 |
Why?
|
| Neoplasms | 5 | 2014 | 21683 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 11727 | 0.050 |
Why?
|
| Immunocompetence | 1 | 2021 | 137 | 0.050 |
Why?
|
| Treatment Outcome | 11 | 2020 | 63114 | 0.050 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2023 | 306 | 0.050 |
Why?
|
| Myocardium | 1 | 2014 | 4776 | 0.050 |
Why?
|
| Nerve Net | 1 | 2013 | 2174 | 0.050 |
Why?
|
| Patient Care Team | 2 | 2012 | 2531 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2015 | 3265 | 0.050 |
Why?
|
| Boston | 4 | 2017 | 9313 | 0.050 |
Why?
|
| Creatine | 1 | 2023 | 421 | 0.050 |
Why?
|
| Manganese | 1 | 2024 | 408 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2014 | 3743 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2014 | 6442 | 0.050 |
Why?
|
| Remission Induction | 2 | 2019 | 2386 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 21827 | 0.050 |
Why?
|
| Muscle Development | 1 | 2002 | 271 | 0.050 |
Why?
|
| Noise | 1 | 2023 | 279 | 0.050 |
Why?
|
| New England | 1 | 2023 | 1022 | 0.050 |
Why?
|
| Nausea | 1 | 2023 | 673 | 0.050 |
Why?
|
| Mutation | 5 | 2018 | 29786 | 0.050 |
Why?
|
| Cities | 1 | 2023 | 513 | 0.050 |
Why?
|
| Genitalia | 1 | 2021 | 112 | 0.050 |
Why?
|
| Serum Amyloid A Protein | 1 | 2000 | 121 | 0.050 |
Why?
|
| Sarcoma, Synovial | 1 | 2002 | 167 | 0.050 |
Why?
|
| HLA-DQ Antigens | 1 | 2020 | 210 | 0.050 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2183 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2024 | 676 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2021 | 505 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 1106 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 3 | 2023 | 7181 | 0.050 |
Why?
|
| Denmark | 1 | 2022 | 738 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 1838 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2021 | 434 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2000 | 258 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 8949 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 2010 | 1583 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
| Cytomegalovirus | 2 | 2021 | 732 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2013 | 480 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2001 | 657 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2013 | 489 | 0.040 |
Why?
|
| Zinc | 1 | 2024 | 684 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 2012 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 531 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 849 | 0.040 |
Why?
|
| Sarcoidosis | 1 | 2004 | 506 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 13102 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2005 | 1352 | 0.040 |
Why?
|
| Agricultural Workers' Diseases | 1 | 1998 | 29 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 17446 | 0.040 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 9438 | 0.040 |
Why?
|
| Exercise Test | 2 | 2017 | 2074 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4204 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2013 | 4043 | 0.040 |
Why?
|
| Budesonide | 1 | 2019 | 154 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2021 | 767 | 0.040 |
Why?
|
| Lead | 1 | 2024 | 852 | 0.040 |
Why?
|
| Fruit | 1 | 2024 | 1142 | 0.040 |
Why?
|
| Chemotaxis | 1 | 2021 | 607 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2023 | 648 | 0.040 |
Why?
|
| Epithelium | 2 | 2018 | 1679 | 0.040 |
Why?
|
| Vegetables | 1 | 2024 | 1182 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2002 | 5179 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2018 | 198 | 0.040 |
Why?
|
| Liver | 2 | 2021 | 7474 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2019 | 462 | 0.040 |
Why?
|
| Asthma | 1 | 2016 | 6011 | 0.040 |
Why?
|
| Public Health | 2 | 2022 | 2603 | 0.040 |
Why?
|
| Organoids | 1 | 2003 | 701 | 0.040 |
Why?
|
| North America | 1 | 2021 | 1249 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2022 | 1654 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 1877 | 0.040 |
Why?
|
| Medicare | 2 | 2012 | 6566 | 0.040 |
Why?
|
| Vehicle Emissions | 1 | 2022 | 665 | 0.040 |
Why?
|
| Nitrogen Dioxide | 1 | 2020 | 490 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2018 | 10252 | 0.040 |
Why?
|
| Utah | 1 | 2017 | 126 | 0.040 |
Why?
|
| Carbonated Beverages | 1 | 2018 | 214 | 0.040 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2017 | 59 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 8863 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10180 | 0.040 |
Why?
|
| Insulin | 2 | 2017 | 6580 | 0.040 |
Why?
|
| Leg | 2 | 1992 | 1116 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2019 | 389 | 0.040 |
Why?
|
| Infant Formula | 1 | 2018 | 199 | 0.040 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2016 | 27 | 0.040 |
Why?
|
| Sigmoidoscopy | 1 | 2017 | 156 | 0.040 |
Why?
|
| Depression | 1 | 2016 | 7766 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 2645 | 0.040 |
Why?
|
| Dura Mater | 1 | 2018 | 291 | 0.040 |
Why?
|
| Incretins | 1 | 2017 | 88 | 0.040 |
Why?
|
| Heart Failure | 1 | 2020 | 10900 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2008 | 2133 | 0.040 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2002 | 477 | 0.030 |
Why?
|
| Chicago | 1 | 1997 | 240 | 0.030 |
Why?
|
| Gliadin | 1 | 2016 | 79 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2016 | 195 | 0.030 |
Why?
|
| Intelligence | 1 | 2021 | 920 | 0.030 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2016 | 47 | 0.030 |
Why?
|
| Propensity Score | 1 | 2023 | 1781 | 0.030 |
Why?
|
| Neutropenia | 1 | 2021 | 895 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 4386 | 0.030 |
Why?
|
| Aging | 1 | 2015 | 8664 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2023 | 1035 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 2 | 2018 | 2635 | 0.030 |
Why?
|
| Cost Control | 1 | 1998 | 624 | 0.030 |
Why?
|
| Milk | 1 | 2018 | 450 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2021 | 1539 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 2029 | 0.030 |
Why?
|
| Survival Rate | 4 | 2020 | 12788 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2022 | 961 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2021 | 4286 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2021 | 1125 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2019 | 1147 | 0.030 |
Why?
|
| Dyspnea | 1 | 2023 | 1303 | 0.030 |
Why?
|
| Aminoisobutyric Acids | 1 | 1995 | 38 | 0.030 |
Why?
|
| Gadolinium DTPA | 2 | 2012 | 836 | 0.030 |
Why?
|
| Wrist | 1 | 2017 | 224 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 235 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2017 | 4420 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2016 | 297 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 977 | 0.030 |
Why?
|
| Microdialysis | 1 | 1995 | 158 | 0.030 |
Why?
|
| Pain | 1 | 2010 | 4986 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2021 | 1241 | 0.030 |
Why?
|
| Transglutaminases | 1 | 2016 | 194 | 0.030 |
Why?
|
| Gastrins | 1 | 2014 | 81 | 0.030 |
Why?
|
| Chemokine CCL11 | 1 | 2014 | 129 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 2861 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3271 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 6386 | 0.030 |
Why?
|
| Hyperplasia | 2 | 2010 | 1185 | 0.030 |
Why?
|
| Colitis, Collagenous | 1 | 2014 | 26 | 0.030 |
Why?
|
| Tenascin | 1 | 2014 | 59 | 0.030 |
Why?
|
| Canada | 1 | 2020 | 2065 | 0.030 |
Why?
|
| Temperature | 1 | 2021 | 2206 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2019 | 608 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2023 | 1889 | 0.030 |
Why?
|
| Endometrium | 1 | 2017 | 424 | 0.030 |
Why?
|
| Interleukins | 1 | 2019 | 791 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1850 | 0.030 |
Why?
|
| Sensation Disorders | 1 | 2015 | 155 | 0.030 |
Why?
|
| Tibial Arteries | 1 | 1994 | 57 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2005 | 2119 | 0.030 |
Why?
|
| Pancreatectomy | 2 | 2012 | 804 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2023 | 1941 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2003 | 4217 | 0.030 |
Why?
|
| Inservice Training | 1 | 1997 | 392 | 0.030 |
Why?
|
| Length of Stay | 2 | 1998 | 6309 | 0.030 |
Why?
|
| China | 1 | 2020 | 2248 | 0.030 |
Why?
|
| Melanoma | 2 | 2009 | 5510 | 0.030 |
Why?
|
| Uric Acid | 1 | 2019 | 766 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2000 | 2225 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2016 | 793 | 0.030 |
Why?
|
| Baltimore | 1 | 2014 | 231 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2002 | 1581 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2077 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2009 | 6314 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 1785 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2003 | 2942 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 8037 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 432 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2000 | 1173 | 0.030 |
Why?
|
| Nursing Staff, Hospital | 1 | 1997 | 346 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 3870 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2915 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2013 | 8436 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2013 | 131 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1995 | 1386 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 1463 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2013 | 128 | 0.030 |
Why?
|
| Locomotion | 1 | 2015 | 378 | 0.030 |
Why?
|
| Popliteal Vein | 1 | 1992 | 43 | 0.030 |
Why?
|
| ras Proteins | 2 | 2012 | 1060 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 1995 | 576 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2018 | 9146 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1995 | 1420 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2009 | 2503 | 0.030 |
Why?
|
| Mucin-2 | 1 | 2012 | 49 | 0.030 |
Why?
|
| Data Collection | 1 | 2022 | 3341 | 0.030 |
Why?
|
| Epithelioid Cells | 1 | 2012 | 71 | 0.030 |
Why?
|
| Observer Variation | 1 | 2018 | 2593 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 2 | 1994 | 793 | 0.030 |
Why?
|
| Arm | 1 | 2015 | 589 | 0.030 |
Why?
|
| Mucin 5AC | 1 | 2012 | 93 | 0.030 |
Why?
|
| Femoral Vein | 1 | 1992 | 159 | 0.030 |
Why?
|
| Anaphylaxis | 1 | 2019 | 746 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2016 | 695 | 0.030 |
Why?
|
| Workflow | 1 | 2016 | 847 | 0.030 |
Why?
|
| Serum | 1 | 2013 | 214 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2016 | 970 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14557 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2016 | 495 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2017 | 1758 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2016 | 1179 | 0.030 |
Why?
|
| Sex Factors | 2 | 2015 | 10397 | 0.030 |
Why?
|
| Glycine | 1 | 1995 | 671 | 0.020 |
Why?
|
| Iliac Artery | 1 | 1993 | 364 | 0.020 |
Why?
|
| Allergens | 1 | 2018 | 1320 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2012 | 332 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2019 | 2751 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2634 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9274 | 0.020 |
Why?
|
| C-Reactive Protein | 2 | 2013 | 3778 | 0.020 |
Why?
|
| Leukocytes | 1 | 2019 | 2043 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2012 | 341 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1995 | 1572 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2015 | 592 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1184 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2012 | 588 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2017 | 19229 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3597 | 0.020 |
Why?
|
| Pneumocystis | 1 | 1990 | 57 | 0.020 |
Why?
|
| Energy Intake | 1 | 2018 | 2148 | 0.020 |
Why?
|
| Potassium | 1 | 1995 | 1336 | 0.020 |
Why?
|
| Apoptosis | 3 | 2017 | 9727 | 0.020 |
Why?
|
| Osteomyelitis | 1 | 2014 | 402 | 0.020 |
Why?
|
| Aortic Valve | 1 | 2020 | 1922 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2016 | 899 | 0.020 |
Why?
|
| Antigens, Fungal | 1 | 1990 | 70 | 0.020 |
Why?
|
| Cognition | 2 | 2021 | 6770 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 611 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2018 | 1338 | 0.020 |
Why?
|
| Expert Systems | 1 | 2010 | 81 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 2025 | 0.020 |
Why?
|
| Forearm | 1 | 2012 | 409 | 0.020 |
Why?
|
| Secretin | 1 | 2010 | 57 | 0.020 |
Why?
|
| Mitochondria | 1 | 2023 | 3520 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2726 | 0.020 |
Why?
|
| Common Bile Duct | 1 | 2010 | 109 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2011 | 411 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1547 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 1801 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2009 | 118 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2373 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2017 | 1158 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2020 | 5974 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2012 | 981 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2013 | 3420 | 0.020 |
Why?
|
| Risk | 1 | 2022 | 9687 | 0.020 |
Why?
|
| Age Distribution | 1 | 2015 | 2902 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4644 | 0.020 |
Why?
|
| Microscopy | 1 | 2014 | 903 | 0.020 |
Why?
|
| Phenotype | 2 | 2021 | 16365 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1995 | 1169 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2012 | 5391 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 2126 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2010 | 211 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 3616 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 16689 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2013 | 1099 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9734 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2216 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1995 | 1121 | 0.020 |
Why?
|
| Neutrophils | 1 | 2021 | 3719 | 0.020 |
Why?
|
| Genes, APC | 1 | 2009 | 159 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1990 | 249 | 0.020 |
Why?
|
| Reaction Time | 1 | 2015 | 2097 | 0.020 |
Why?
|
| Femoral Artery | 1 | 1993 | 845 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 1995 | 1178 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 4262 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2017 | 2499 | 0.020 |
Why?
|
| Bile Ducts | 1 | 2010 | 284 | 0.020 |
Why?
|
| Problem-Based Learning | 1 | 2012 | 361 | 0.020 |
Why?
|
| Mortality | 1 | 2020 | 2864 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2000 | 2987 | 0.020 |
Why?
|
| International Cooperation | 1 | 2015 | 1420 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 2418 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 1265 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2010 | 454 | 0.020 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2011 | 397 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 8428 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2016 | 3206 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 1988 | 0.020 |
Why?
|
| Educational Status | 1 | 2015 | 2540 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2016 | 2035 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 976 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3701 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2012 | 543 | 0.020 |
Why?
|
| Ankle | 1 | 2010 | 327 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2008 | 3913 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 18029 | 0.020 |
Why?
|
| Duodenoscopy | 1 | 2007 | 52 | 0.020 |
Why?
|
| Psychometrics | 1 | 2016 | 3002 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2010 | 504 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 2421 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3508 | 0.020 |
Why?
|
| Logistic Models | 1 | 2022 | 13408 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2016 | 1339 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 9959 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 3582 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2017 | 2266 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2017 | 4161 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 12072 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2023 | 4558 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12026 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6895 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 3689 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5217 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6544 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2002 | 4034 | 0.020 |
Why?
|
| Dumping Syndrome | 1 | 2005 | 18 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3528 | 0.020 |
Why?
|
| Endosonography | 1 | 2010 | 610 | 0.020 |
Why?
|
| Chemokine CXCL5 | 1 | 2005 | 27 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.020 |
Why?
|
| Diazoxide | 1 | 2005 | 57 | 0.020 |
Why?
|
| Base Sequence | 1 | 2017 | 12797 | 0.020 |
Why?
|
| Diet | 1 | 2024 | 7939 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4364 | 0.020 |
Why?
|
| Organ Preservation | 1 | 1988 | 331 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1992 | 1275 | 0.020 |
Why?
|
| Registries | 2 | 2017 | 8089 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1993 | 1873 | 0.020 |
Why?
|
| Octreotide | 1 | 2005 | 145 | 0.020 |
Why?
|
| Stem Cells | 1 | 2018 | 3567 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 2889 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2013 | 1774 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8642 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1504 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7785 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2016 | 2958 | 0.020 |
Why?
|
| Diet Therapy | 1 | 2005 | 154 | 0.020 |
Why?
|
| Europe | 1 | 2011 | 3339 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 1988 | 0.010 |
Why?
|
| Reoperation | 2 | 2010 | 4201 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 2 | 2002 | 1799 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1992 | 1401 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 5524 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 3923 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 1992 | 1640 | 0.010 |
Why?
|
| Gangrene | 1 | 2003 | 82 | 0.010 |
Why?
|
| Family | 1 | 2014 | 3147 | 0.010 |
Why?
|
| Genes, erbB-2 | 1 | 2004 | 162 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2012 | 2488 | 0.010 |
Why?
|
| Life Tables | 2 | 1994 | 370 | 0.010 |
Why?
|
| Genes, erbB-1 | 1 | 2004 | 161 | 0.010 |
Why?
|
| Ischemia | 1 | 1992 | 1907 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15540 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2282 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 7722 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2715 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 2002 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
| Radiography | 1 | 2014 | 7023 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1989 | 1198 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 2003 | 6171 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 12354 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4560 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2013 | 2575 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 1150 | 0.010 |
Why?
|
| Granuloma | 1 | 2004 | 319 | 0.010 |
Why?
|
| Appendicitis | 1 | 2009 | 645 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2017 | 3537 | 0.010 |
Why?
|
| Chromones | 1 | 2002 | 154 | 0.010 |
Why?
|
| Gallbladder | 1 | 2003 | 302 | 0.010 |
Why?
|
| Macrophages | 1 | 2016 | 5655 | 0.010 |
Why?
|
| Gene Expression | 1 | 2015 | 7799 | 0.010 |
Why?
|
| Calcium | 1 | 1995 | 5756 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9849 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2002 | 245 | 0.010 |
Why?
|
| Suspensions | 1 | 2000 | 65 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 1470 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 2010 | 1540 | 0.010 |
Why?
|
| Capsules | 1 | 2000 | 196 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 4554 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 552 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2002 | 876 | 0.010 |
Why?
|
| Computational Biology | 1 | 2012 | 3521 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 2 | 1994 | 549 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2003 | 673 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1992 | 2538 | 0.010 |
Why?
|
| Steroids | 1 | 2004 | 930 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 1988 | 1153 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2012 | 5985 | 0.010 |
Why?
|
| Necrosis | 1 | 2003 | 1643 | 0.010 |
Why?
|
| Cocarcinogenesis | 1 | 1998 | 54 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2892 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2000 | 376 | 0.010 |
Why?
|
| Morpholines | 1 | 2002 | 571 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2004 | 1261 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2004 | 11031 | 0.010 |
Why?
|
| X Chromosome | 1 | 2002 | 814 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6489 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 862 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2004 | 1092 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2000 | 2232 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 4776 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5442 | 0.010 |
Why?
|
| Genome, Human | 1 | 2010 | 4420 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1989 | 5007 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11524 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 1420 | 0.010 |
Why?
|
| Israel | 1 | 1998 | 796 | 0.010 |
Why?
|
| Pesticides | 1 | 1998 | 287 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3507 | 0.010 |
Why?
|
| Quinazolines | 1 | 2002 | 1356 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2000 | 847 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2005 | 1591 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5172 | 0.010 |
Why?
|
| Comorbidity | 1 | 2009 | 10388 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 4568 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 12208 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 5882 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 7149 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 4933 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 2938 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4838 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2002 | 4851 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3798 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 15997 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6364 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13695 | 0.010 |
Why?
|
| Veins | 1 | 1994 | 770 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1994 | 2124 | 0.010 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1992 | 277 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1992 | 987 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 1998 | 1796 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2002 | 11483 | 0.000 |
Why?
|
| Dogs | 1 | 1988 | 3912 | 0.000 |
Why?
|
| HIV-1 | 1 | 2000 | 6939 | 0.000 |
Why?
|
| Smoking | 1 | 1998 | 8987 | 0.000 |
Why?
|
| Wound Healing | 1 | 1992 | 2785 | 0.000 |
Why?
|
| Tissue and Organ Procurement | 1 | 1988 | 896 | 0.000 |
Why?
|